STATE STREET CORP - PHARMACYTE BIOTECH INC ownership

PHARMACYTE BIOTECH INC's ticker is PMCBD and the CUSIP is 71715X203. A total of 27 filers reported holding PHARMACYTE BIOTECH INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of PHARMACYTE BIOTECH INC
ValueSharesWeighting
Q1 2023$182,166
-50.2%
62,600
-50.0%
0.00%
Q4 2022$365,584
+143.7%
125,200
+100.0%
0.00%
Q3 2022$150,000
+6.4%
62,6000.0%0.00%
Q2 2022$141,000
+64.0%
62,600
+66.5%
0.00%
Q1 2022$86,00037,6000.00%
Other shareholders
PHARMACYTE BIOTECH INC shareholders Q1 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 1,217,828$3,045,0000.44%
Ayrton Capital LLC 153,130$383,0000.36%
Shay Capital LLC 662,337$1,656,0000.27%
EQUITEC PROPRIETARY MARKETS, LLC 258,694$647,0000.09%
Anson Funds Management LP 193,400$484,0000.05%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 44,944$112,0000.00%
Jump Financial, LLC 10,300$26,0000.00%
Schonfeld Strategic Advisors LLC 30,400$76,0000.00%
Aspire Private Capital, LLC 800$2,0000.00%
OSAIC HOLDINGS, INC. 1,763$5,0000.00%
View complete list of PHARMACYTE BIOTECH INC shareholders